Injections Business

With its main business focused on heparin and LMWH injections,
Techdow is now a leading exporter of LMWH injections in China.

Market Leadership in the Heparin Business

  • The First

    The first enoxaparin sodium biosimilar approved by the EMA of the EU

  • An Industry Leader

    A leading exporter of LMWH injections in China

  • The First

    The first generic enoxaparin sodium injection approved by China NMPA

  • The First

    One of the first few Chinese pharmaceutical companies with its own sales teams for formulated products in the EU market. To date, Techdow's enoxaparin sodium injections have recorded a total sales of approximately 540 million pre-filled syringes in the European market, making Techdow a market leader in the region1.

    1. Based on 2017-2023 statistics from IQVIA database

  • The First Selected

    Techdow's enoxaparin sodium injection (Prolongin®) is the first enoxaparin product selected by the 8th Centralized National Procurement in China

  • Global Presence

    Techdow's enoxaparin sodium injections are sold in over 40 countries and regions around the world and included in the national insurance systems of the EU, UK, and Switzerland.

The Advantages of Techdow's Enoxaparin Sodium Injections

Contact Us

  • China Market

    Tel: +86-0755-86108941

    Email: chinasales1@hepalink.com

  • European Market

    Tel: +86-0755-26980200-2502

    Email: eu_marketing@hepalink.com

  • The U.S. Market

    Tel: +86-0755-26980200-2505

    Email: sales_us@techdow.com

  • Rest of the World

    Tel: +86-0755-26037643

    Email: fdf.sales@techdow.com

Legal statement   ·   Environmental Disclosure

Copyright ©2022 Shenzhen Techdow Pharmaceutical Co., Ltd